American Society of Hirudotherapy

Venous Leg Ulcer

Off-label adjunct to compression therapy; the journal evidence is one 20-patient uncontrolled series in complicated varicose veins plus case reports; the books add an older report on trophic ulcers of unspecified origin (see “What the books describe” below).

Tier B — RCT-supported off-labelStudied off-label: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
No — investigated off-label. The FDA cleared medicinal leeches in 2004 only for venous congestion in microsurgical reconstruction (K040187). Use for venous leg ulcers is investigational and not FDA-evaluated; published evidence is limited to one small uncontrolled series and a few single-patient case reports.
What evidence exists?
No randomized trial was identified. The published evidence is one small uncontrolled series of 20 patients with complicated varicose veins (Bapat 1998) and a few single-patient case reports, so the evidence is weaker than for some other conditions. A medical book by Baskova and Isakhanyan also summarizes an older report on trophic (slow-healing) skin ulcers that is not stated to concern venous ulcers (see “What the books describe” below). Leeches must never be placed on the ulcer base. Compression bandaging remains the foundation of care; leech therapy is an adjunct for ulcers that have not healed with compression alone.
Main risks
  • Bleeding and oozing from each bite site for hours to a full day
  • Mild anemia if many leeches are used across multiple sessions
  • Wound infection, including Aeromonas infection from leech gut bacteria (your team may give an antibiotic such as ciprofloxacin)
  • Itching, redness, irritation, and bruising at the bite sites
  • Allergic reaction to leech saliva (uncommon)
  • New skin pigmentation changes or scars at the bite sites
  • Slow progress — many ulcers take 12 weeks or more to close even with leech therapy
Who should not consider this
  • Patients taking blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, or heparin
  • Patients with hemophilia or other inherited bleeding disorders
  • Patients with anemia
  • Patients with a weakened immune system, especially severe neutropenia
  • Patients with active wound infection (the wound needs cleaning and antibiotic treatment first)
  • Patients whose ulcer has a significant artery problem (ABI under 0.8) — needs vascular surgery evaluation
  • Patients with active deep vein thrombosis (within last 2 weeks)
What to ask your clinician
  • Has my ulcer been properly evaluated with an ABI to make sure it is mainly venous, not arterial?
  • Am I receiving the right compression bandage system and is it being applied correctly?
  • Should I be referred to a wound clinic or vascular surgeon before trying leech therapy?
  • What is the practitioner's experience with leech therapy for venous ulcers?
  • What antibiotic plan do you use for Aeromonas prevention, especially with open wounds nearby?
  • How will my blood count be monitored, and at what level would you transfuse?
  • What is the cost, and is any of it covered by insurance? (typically not)
When to seek urgent care
  • Bleeding from a bite site lasting more than 24 to 48 hours
  • Spreading redness, warmth, pus, or red streaks around the wound or bite sites (cellulitis)
  • Fever above 38.0 C / 100.4 F or chills
  • Sudden new severe leg pain, swelling, or warmth (possible DVT)
  • Hives, facial swelling, throat tightness, or breathing difficulty

What this does NOT mean

  • It does not mean leech therapy is FDA-cleared for venous ulcers — it is not.
  • It does not mean compression bandaging can be stopped — compression remains the foundation of healing.
  • It does not mean every ulcer will heal with leech therapy — the main published series (20 patients, no comparison group) reported all ulcers healed, and so small an uncontrolled report cannot predict how an individual ulcer will respond.
  • It does not mean the ulcer will not come back — recurrence is common in venous disease without ongoing compression and lifestyle measures.
  • It does not mean leeches replace specialized wound care or vascular surgery referral when those are indicated.

Clinical Profile

Category
Vascular
ICD-10
I83.001, I83.002, I83.003, I83.004, I83.005, L97.819, L97.929
Safety tier
Medium

Evidence Summary

Venous leg ulcers occur in 1-3% of adults over 65 and have a 12-month healing rate of only 50-70% even with optimal compression. Evidence for adding leech therapy is limited to one prospective uncontrolled series of 20 patients with complicated varicose veins, in which all ulcers were reported to heal (Bapat 1998), and single-patient case reports (for example Sharma 2020 and Wani 2025); none had a comparison group, so no reliable healing rate can be attributed to it. Beyond these, the 2004 monograph by Baskova and Isakhanyan retells the Bapat series and summarizes a further series of trophic ulcers whose venous origin is not specified (see “What the books describe” below). The proposed mechanism is that salivary fibrinolytic and anti-inflammatory components may disrupt the pericapillary fibrin cuff thought to impair oxygen diffusion and reduce local wound inflammation. Leeches must NEVER be placed on the ulcer base. No randomized controlled trial of leech therapy for venous ulcers was identified in PubMed, Europe PMC or Crossref; compression remains first-line and leech therapy is investigational.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Baskova and Isakhanyan list varicose ulcers among the indications for hirudotherapy[B1].
  • In a study by Bapat and colleagues (1998), as described by Baskova and Isakhanyan, all ulcers healed after hirudotherapy in 20 patients with varicose ulcers, and swelling decreased in almost all of them; the book goes on to say that the question requires further verification[B1].
  • Michalsen et al., describing an Indian uncontrolled study of 20 patients with venous ulcers, stress that without a comparison group it is impossible to say whether it was specifically the leeches that had an effect[B3].
  • Baskova and Isakhanyan also cite Shchekotov's summary (1980) of 67 patients with trophic ulcers (the book does not say whether they were venous): the ulcer was gradually cleaned and closed, and the results are described as good[B1].
  • Michalsen et al. advise against placing leeches directly on the ulcer; regarding poorly healing wounds, for example leg ulcers, they write that a bite at the affected spot itself may become a focus of new ulcers[B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Active deep vein thrombosis (acute phase)
  • Critical limb ischemia (ABI <0.4)
  • Active wound infection (clean before leeching)
  • Arterial component to ulcer (ABI <0.8)

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.